1312579-40-0

Basic information

• Product Name: 3-[4-chloro-1-methyl-2-(4-piperazin-1-yl-phenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-N-(2-dimethylamino-ethyl)-benzamide
• Synonyms: 3-[4-chloro-1-methyl-2-(4-piperazin-1-yl-phenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-N-(2-dimethylamino-ethyl)-benzamide
• CAS NO: 1312579-40-0
• Molecular Weight: 517.074
• Mol File: 1312579-40-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-[4-chloro-1-methyl-2-(4-piperazin-1-yl-phenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-N-(2-dimethylamino-ethyl)-benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[4-chloro-1-methyl-2-(4-piperazin-1-yl-phenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-N-(2-dimethylamino-ethyl)-benzamide(1312579-40-0)
• EPA Substance Registry System: 3-[4-chloro-1-methyl-2-(4-piperazin-1-yl-phenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-N-(2-dimethylamino-ethyl)-benzamide(1312579-40-0)

Safety Data

• Hazardous Substances Data: 1312579-40-0(Hazardous Substances Data)

Upstream product

• 55052-28-3 4-chloro-7-azaindole 
• 457613-78-4 4-(4-(tert-butoxycarbonyl)piperazin-1-yl)phenylboronic acid 
• 940948-29-8 4-chloro-2-iodo-1H-pyrrolo[2,3-b]pyridine 
• 840521-76-8 N-(2-(dimethylamino)ethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide 
• 1312581-11-5 4-[4-(4-chloro-3-iodo-1-methyl-1H-pyrrolo[2,3-b]pyridin-2-yl)-phenyl]-piperazine-1-carboxylic acid tert-butyl ester 
• 1312581-09-1 4-chloro-2-iodo-1-methyl-1H-pyrrolo[2,3-b]pyridine 
• 1312581-10-4 4-[4-(4-chloro-1-methyl-1H-pyrrolo[2,3-b]pyridin-2-yl)-phenyl]-piperazine-1-carboxylic acid tert-butyl ester 
• 1312581-04-6 4-chloro-1-(methoxymethyl)-1H-pyrrolo[2,3-b]pyridine 
• 1312581-05-7 4-chloro-2-iodo-1-methoxymethyl-1H-pyrrolo[2,3-b]pyridine 

Relevant articles and documents

AZAINDOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

The disclosure relates generally to compounds that inhibit Pim kinases. Provided herein are N-substituted azaindoles, or pharmaceutically acceptable salts thereof, which are useful as selective inhibitors of Pim kinases. The disclosure also relates to pharmaceutical compositions comprising these compounds, processes for their preparation, and methods of using the same.